DDX53 and neoplasm: Magnetic resonance imaging (MRI)-based longitudinal analyses – in MC38- (Figure 2C and Figure 2—figure supplement 1E) or CT26-challenged (Figure 2D and Figure 2—figure supplement 1F) animals – revealed that 100% of NaCl-treated mice (Figure 2E and F) develop multiple metastatic tumor lesions by days 21 and 28 after challenge and no mice displayed detectable tumors in other organs.